MIT’s Solve Global Challenges 2025

Deadline: April 17, 2025

Competitions

Creative Ideas Tech & IT

Location(s)

  • Online
  • United States of America
Cambridge, MA

Overview

In order to find and scale the best ideas to the most intractable issues of our time, we launch open innovation challenges. We built a research-backed platform and a proven methodology that seeks tech-based solutions from anyone, anywhere in the world. Our reach is vast, with tens of thousands of applicants from nearly every corner of the world.

And we’re not done yet. 

Details

Solve at MIT is our flagship annual event held on the MIT campus in Cambridge, MA, bringing together over 300 leaders from the tech industry, business, philanthropy, government, and civil society. Solvers and their solutions will be featured on stage, in online and written materials, and through dedicated challenge workshops. Solve staff will continue supporting Solvers to match-make partnerships with our community members who will help make Solvers’ solutions a reality.

Solve challenges are a unique opportunity to bring your ideas and talent to a growing global community tackling the most important challenges facing the world today.

Solve was born out of MIT in 2015, a natural offshoot of MIT’s commitment to open technological innovation, and its long commitment to actionable thought leadership in the public sphere.

 

 

How Challenges Work

Each year Solve seeks solutions from tech innovators around the world for its Global Challenges, and anyone can submit a solution. Finalists are invited to pitch their solutions at Solve Challenge Finals during UN General Assembly Week in New York City in September. Selected Solver teams will join a supportive community of peers, funders, and experts to help advance their work; receive mentorship and strategic advice from Solve and MIT networks; attend Solve at MIT, our annual flagship event in May; and receive access to significant additional prize funding from our partners. 

In the last two years, Solve’s community has committed more than $7 million in funding to Solver teams, in addition to in-kind support such as mentorship, technical expertise, media and conference exposure, and business and entrepreneurship training.

Opportunity is About


Eligibility

Candidates should be from:


Description of Ideal Candidate

Who can apply to Solve's Challenges?

Anyone, anywhere around the world aged 13 and older can submit a solution to Solve's Challenges. You can be an individual, a team, or an organization. You can be an applicant from previous years or already part of our community. If you have a relevant solution, we hope you'll apply.

Solve considers solutions at all stages of development:

  • Idea: We welcome you to submit your solution to participate in the discussion, but please note that solutions that are still only at the concept stage are unlikely to be selected. You have until the submission deadline to prototype and experiment with your idea!
  • Prototype: A venture building and testing its product, service, or business model. Typically described as "Pre-Seed" if For Profit.
  • Pilot: An enterprise deploying a tested product, service, or business model in at least one community. Hybrids and For Profits would typically be in a "Seed" round and generating revenue (whether or not they are cash flow positive).
  • Growth: An enterprise with an established product, service, or business model rolled out, which is poised for further growth in multiple communities or countries. Organizations at this stage should have a clear path to sustainability. For Profits at this stage would be "Seed" or "Series A."
  • Scale: A sustainable enterprise working in several communities or countries and that is looking to scale significantly, focusing on increased efficiency. For Profits in this stage would be "Series A" or "Series B."

The most important thing is that your solution will solve the Challenge posed. And, we’re MIT! So, every solution must include technology -- whether new or existing -- as a key component.

How will my solution be evaluated?

Our judges are experts and leaders from across industries. We’ll announce who the judges are within each challenge.

In the first round, Solve staff will perform an initial screening of all applications for completeness, for coherency, and for whether the solution appropriately addresses the challenge. Then our judges will score the screened applications to determine finalists. Here are the criteria the judges will use to score the applications on the website:

  • Alignment: The solution addresses the challenge that has been set forth using technology.
  • Potential for Impact: The planned implementation of the solution has the potential to impact lives.
  • Scalability: The solution can be grown and scaled to affect the lives of more people.
  • Feasibility: It is feasible to implement the solution, and the team has a plan for the solution to sustain itself financially.
  • Innovative Approach: This is a new technology, a new application of a technology, a new business model, or a new process for solving the challenge

In the second round, each finalist will pitch before the challenge judges and a live audience. The judges will determine which solutions are the most promising. This new Solver class will receive support and partnership from the Solve community.


Dates

Deadline: April 17, 2025


Cost/funding for participants

A prize fund of up to £1,000,000 will be awarded, with an aim to award a grand prize of £500,000 in each category of the Challenge (Stock Control and Substandard and Falsified Antibiotics). Other prizes may be made at the discretion of the Judges e.g. runner-up prizes or honourable mentions for solutions outstandingly meeting some criteria.

The exact amount of the prize for each winner will depend on the solution’s needs for development, deployment, and scaling over the next two years.

+ More Info / Application Save Opportunity Un-save Opportunity


find-dream
Search from 1759 opportunities in 164 countries

Internships, scholarships, student conferences and competitions.